PUNE, India, December 21, 2017 /PRNewswire/ --
The report "Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022", studies the global Clinical Laboratory Services Market over the forecast period of 2017 to 2022. The market is projected to reach USD 146.41 Billion by 2022 from USD 113.44 Billion in
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 73 market data Tables and 31 Figures spread through 167 Pages and in-depth TOC on "Clinical Laboratory Services Market"
Early buyers will receive 10% customization on this report
Factors such as the rising demand for early and accurate disease diagnosis; growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures; and rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures, are driving the growth of the Clinical Laboratory Services Market.
Based on specialty, the genetic testing segment is expected to witness the highest growth during the forecast period.
On the basis of specialty, the Clinical Laboratory Services Market is categorized into seven major testing categories, namely, clinical chemistry, microbiology, hematology, immunology, cytology, genetic, and drugs of abuse testing. In 2017, the clinical chemistry segment is expected to account for the largest share of the market. This can be attributed to the large volume of clinical chemistry tests performed compared to other specialties, growing global disease burden of chronic and infectious disorders, technological innovations in clinical chemistry, and improving healthcare infrastructure in developing nations.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=554
Based on type, routine chemistry testing segment is estimated to have the largest share of the clinical chemistry market in 2017.
The clinical chemistry segment is further sub-segmented by type into routine chemistry testing, endocrinology chemistry testing, therapeutic drug monitoring (TDM) testing, specialized chemistry testing, and other clinical chemistry testing. The routine chemistry testing segment is expected to account for the largest share of the clinical chemistry market owing to the rising awareness of the importance of regular health checkups and the growing government initiatives to promote benefits and importance of early disease diagnosis.
Independent and reference laboratories are expected to witness the highest growth during the forecast period.
By provider, the market is segmented into independent and reference laboratories, hospital-based laboratories; and nursing and physician office-based laboratories. The independent and reference laboratories segment is expected to account for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large market share of independent & reference laboratories is primarily attributed to the large number of patient diagnostic tests undertaken in these labs, competitive benefits offered by these providers over hospital-based laboratories, significant reimbursement coverage, and ongoing consolidation & streamlining of diagnostic laboratories across major markets.
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=554
Europe is expected to dominate the Clinical Laboratory Services Market in 2017.
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is expected to account for the largest share of the market in 2017, followed by North America. The market in Europe is primarily driven by the rising geriatric population, increasing the incidence of chronic disease conditions, and growing public and private funding for clinical laboratory test research.
The major players in Clinical Laboratory Services Market include Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), and DaVita Healthcare Partners (US). Other key players in this market include Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories (US), Sonic Healthcare Limited (UK), Clinical Reference Laboratory, Inc. (US), Cerba HealthCare (France), ACM Medical Laboratory (US), ADICON Clinical Laboratory (China), Amedes Holding GmbH (Germany); and others.
Browse Related Reports:
Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment - Forecasts to 2021
Microbial Identification Market by -Product & Service (Instruments, Consumables, Identification Services), Method (Phenotypic, Proteomics-based, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food), End User - Global Forecast to 2022
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: firstname.lastname@example.org
Visit Our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Subscribe to our Free Newsletters!
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...View All